Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 1821-1830 Newer>

Managed Care February 2005 John Carroll	Just What Can We Expect From New Head of HHS? How much will plans have to "be like Mike" -- Leavitt, that is. The influence of the secretary of health and human services reaches beyond the public sector.
Managed Care February 2005	Medicare's Drug Coverage Seeks To Strike Compromise Health plan officials are still trying to determine just how the final rules for the new Medicare prescription drug benefit will affect them, because it appears that government officials tried their best to address the competing concerns of all players.
Managed Care February 2005	Class-Action Suit By 600,000 Docs Heading To Court Discusses a lawsuit filed by about 600,000 physicians against some of the biggest health plans in the country: Humana, PacifiCare, UnitedHealthcare, WellPoint, Anthem, and Health Net. Aetna and Cigna were named but settled out of court.
Managed Care February 2005	Different methods used to gauge doc performance Just how physician performance is measured has become more important as P4P programs proliferate.
Managed Care February 2005	Headlines On Deadline ... The data used by the Centers for Disease Control and Prevention were exaggerated... Health care Web sites may be chock full of information, but many people 65 or older haven't taken advantage... etc.
Managed Care February 2005	Pediatric groups' revenue increase falls behind boost in practice costs Revenue in pediatric medical practices has not kept pace with cost increases, according to the Medical Group Management Association Survey for Pediatric Practices: 2004 Report Based on 2003 Data.
Managed Care February 2005	Biggest increases in specialty drug costs seen in rheumatologic, cancer, and hemophilia agents Medco reports that of the top seven contributors to specialty drug costs, agents for rheumatologic conditions (80.6 percent), cancer (33.2 percent), and hemophilia (28.4 percent) demonstrated the greatest percent change in cost from 2002 to 2003.
Managed Care February 2005 Thomas Morrow	Competition Heralds Beginning of Bio-Generics There is very little competition in the biopharmaceutical sector. With the introduction of generic forms of human growth hormone, can managed care get a lower price?
BusinessWeek March 7, 2005 Michael Arndt	Rewiring The Body First came pacemakers. Now exotic implants are bringing new hope to victims of epilepsy, paralysis, depression, and other diseases. And some of the biggest names in health care are in a scramble to get into the market.
BusinessWeek March 7, 2005 Amy Barrett	A Drug Company On Growth Hormones By adding Accredo to its portfolio, Medco gains a strong presence in the area of specialty drugs. Investors sent Medco's stock down slightly on news of the deal. But they give company chief David B. Snow Jr. credit for putting Medco in a position to capitalize on new opportunities.
<Older 1821-1830 Newer> Return to current articles.